Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
about
Genetic variations in colorectal cancer risk and clinical outcomeThe genetics of cancer riskBET bromodomain inhibition as a therapeutic strategy to target c-MycA beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancersUpregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cellsMYC association with cancer risk and a new model of MYC-mediated repression.Prostate cancer risk alleles are associated with prostate cancer volume and prostate size.A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin.8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.Genetic variation at chromosome 8q24 in osteosarcoma cases and controls.An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development.Molecular genetics of prostate cancer: new prospects for old challengesPost-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexityExpression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer.Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancerPolymorphisms on 8q24 are associated with lung cancer risk and survival in Han ChineseExpression QTL-based analyses reveal candidate causal genes and loci across five tumor types.DNA methylation levels at chromosome 8q24 in peripheral blood are associated with 8q24 cancer susceptibility lociProstate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.Chromosome 8q24-Associated Cancers and MYC.Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapyAssessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detectionAssociation of three 8q24 polymorphisms with prostate cancer susceptibility: evidence from a meta-analysis with 50,854 subjects.The 8q24 gene desert: an oasis of non-coding transcriptional activity.An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice.Analysis of Prostate Cancer Susceptibility Variants in South African Men: Replicating Associations on Chromosomes 8q24 and 10q11.Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.Regulators of gene expression as biomarkers for prostate cancerAn examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer.Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signalingUrinary bladder cancer susceptibility markers. What do we know about functional mechanisms?Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.Blood and tissue biomarkers in prostate cancer: state of the art.Functional enhancers at the gene-poor 8q24 cancer-linked locus.Markers for detection of prostate cancer.The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
P2860
Q27002944-38088CB5-292D-45A2-B5A6-36771F3BF69CQ27013910-91157DA3-F9F0-4850-992D-8E8BC53D9E71Q28247024-2235F908-BC46-47FE-87E6-8252128668FBQ33591695-B6B0195C-A5C7-45F4-B15C-75EFE713DDD7Q33705050-5B3417C5-EBE6-47A7-9C22-2E6DD06933B0Q33790662-A852AA18-9C5A-4530-B0F9-531E26444A61Q33935064-90308C7B-0975-4159-A094-10C0D043DA07Q33981307-4D3D4831-74E1-4841-8A4A-BD90E38B90B3Q33981705-74D81A3F-8838-49C6-9B39-5B4C99D970DDQ34006369-50B4E120-AE78-4CE8-BA8C-188DE0A6B968Q34042362-84C5410B-A03B-40A4-A0B5-8C89DA64F05DQ34085123-6204A21F-65FA-4D16-90D8-A98CEADD650AQ34091855-2FD74663-C4B0-4124-A39F-A109FFFA338DQ34127462-AE843378-83BB-4AE8-8901-F17849BB39E1Q34205770-253FFD87-9E00-4D17-96F0-0EB68F4FE510Q34230381-595AA9D8-BCE4-4698-9227-F036540EFB24Q34292730-62D40EF8-F3F8-4A64-8D29-ACAACF49DEF5Q34316058-B74EC489-2843-4A96-82F2-E4F234D99473Q34359258-327054CA-87C6-4089-A905-4D419C0D3E21Q34430369-36BB754C-C450-4107-BAE4-C7AADA3DFF77Q34633158-82C0BBB4-3734-46CF-B92D-2723718BA598Q34673469-DAACD0EF-B479-49B6-A79A-B8E9A793F019Q34972340-1238C58B-CF1B-4705-9CC3-91B966816824Q35142413-6CCE7185-4884-443C-A2BD-23BAC751D4E4Q35647187-4D168C33-3466-461A-A23D-82F89475E747Q35661317-A26EA430-67CF-4CD3-B9D5-9D05B8AEECF9Q35837515-9FFB394B-DA2C-4C2F-8AC0-F538A96FDC56Q35919877-72E1E32F-2865-42B9-B829-FE3F0DDE880FQ35921154-3C1505B1-B353-4C41-82C9-B66ECDAE54F6Q35996120-48814A69-BA26-4C23-8E49-979F3C9AE8EEQ36245211-39A71C63-D7D0-4A68-8C56-C2278691BD4CQ36439912-96E18EEB-541D-4E16-86F0-4CD11279CFF4Q36663319-D16B6466-09E6-4781-B9E6-79FDF98F75ABQ36915235-D8F12414-B461-4922-855B-2C0C8DAC17E2Q37007328-1AE1DF19-0333-40A2-B659-7C17453C47EAQ37139054-A4B637EF-8CC2-47C6-993F-CC9A09318DECQ37201929-AAAD914E-3C10-4425-946F-3E68A339956BQ37279616-F7154CE5-2A33-4EDE-9E1B-BAA0786C89DCQ37328403-DC0350D8-1DD3-4A1B-892A-1181CD219475Q37390854-CFF1E843-66AD-4C2E-A592-C4E2741B380C
P2860
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
@ast
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
@en
type
label
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
@ast
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
@en
prefLabel
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
@ast
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
@en
P2093
P2860
P50
P1433
P1476
Evaluation of the 8q24 prostate cancer risk locus and MYC expression
@en
P2093
Brian R Fritz
Christine A Beckwith
Daniel W Lin
David G McLeod
Dorota J Hawksworth
Jennifer A Chan
Kathryn L Penney
Kristin G Ardlie
Mark M Pomerantz
Matthew L Freedman
P2860
P304
P356
10.1158/0008-5472.CAN-09-0387
P407
P577
2009-06-23T00:00:00Z